(NASDAQ: ARAY) Accuray's forecast annual revenue growth rate of 4.46% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Accuray's revenue in 2025 is $450,902,000.On average, 4 Wall Street analysts forecast ARAY's revenue for 2026 to be $53,953,779,066, with the lowest ARAY revenue forecast at $51,660,887,966, and the highest ARAY revenue forecast at $55,732,101,427. On average, 4 Wall Street analysts forecast ARAY's revenue for 2027 to be $56,157,130,672, with the lowest ARAY revenue forecast at $53,859,705,926, and the highest ARAY revenue forecast at $57,909,384,573.
In 2028, ARAY is forecast to generate $58,231,273,388 in revenue, with the lowest revenue forecast at $55,948,582,989 and the highest revenue forecast at $59,944,991,303.